The US and Canada have healthcare, life science and medical device industries that are complex and interconnected.

On March 6, President Donald Trump instituted a 25 percent ad valorem rate of duty on goods imported from Canada under the International Emergency Economic Powers Act.[1] The tariffs will not be implemented on goods that comply with the United States-MexicoCanada Agreement until April 2.[2] In turn, Canada has announced a $155 billion tariff package on the US.[3]

Download the full Law360 article, "Mitigating Tariff Risks For Healthcare In US And Canada."



Contacts

Jeff Wurzburg
Jeff Wurzburg
Partner
Email
jeff.wurzburg@nortonrosefulbright.com
T: +1 210 270 9338
Vanessa Grant
Vanessa Grant
Senior Partner
Email
vanessa.grant@nortonrosefulbright.com
T: +1 416 216 4056

Practice areas:

Industry:

Recent publications

Publication

CMS updates price transparency guidance

The Centers for Medicare & Medicaid Services (CMS) has released new Guidance on price transparency, presenting significant challenges for hospitals.

United States | June 09, 2025

Healthcare
SCOTUS reverses DC Circuit; clarifies deferential standard of review

Publication

SCOTUS reverses DC Circuit; clarifies deferential standard of review

Since its enactment in 1970, the National Environmental Policy Act (NEPA) has become a favored tool for opponents seeking to defeat or delay new infrastructure and construction projects.

United States | June 06, 2025

Appellate

Publication

H.B. 40 expands the Texas Business Court’s jurisdiction and geography

The 89th Texas Legislature passed House Bill 40, which expands the jurisdiction of the Texas Business Court and opens the door to the creation of additional Business Court Divisions in the future.

United States | June 05, 2025

Litigation and disputes
Site search

Subscribe and stay up to date with the latest legal news, information and events . . .

Subscribe now